This page will track and monitor when cancers that only affect males are raised in the Senedd. The most common forms are prostate and testicular cancer.

Prostate cancer is the third most common cancer that causes death in Wales, and men are proportionally more likely to die from cancer than women¹.

On October 21st 2026, the Senedd agreed to a non-binding motion tabled by Reform UK calling for prostate cancer to be prioritised in the Welsh Government’s cancer strategy.

Males carrying certain genes (or a family history) may be more at risk of developing prostate cancer, while it’s also more common in black and older men.

Testicular cancer is more common in younger men (under-50s) and white men with a family history of cancer.

Both forms of cancer have a high survival rate if caught early, but this often relies on men seeking medical advice or self-checking (in the case of testicular cancer). There may be cultural barriers to this (men being more reluctant to seek help) and real world barriers (harder to get a timely appointment and the lack of a men’s health plan).

There isn’t a national screening programme for prostate cancer. Though men aged 45-61 with a genetic risk of developing prostate cancer may be offered a test.

A national prostate cancer screening programme has been rejected by health authorities because it produces too many “false positive” results (meaning they show that a man may have cancer when it turns out he doesn’t, leading to overdiagnosis)².

Around 3,000 men are diagnosed with prostate cancer in Wales every year; around 600 men die from it annually. Testicular cancer is less common, with around 100 men diagnosed in Wales each year. Penile cancer is very rare³.